Patent · US Active

Quinazolinedione derivatives as PARP inhibitors

US8080557B2 · kind B2 · utility

2Cited by

2References

18Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Ludo Edmond Josephine Kennis · Lier, BE
Josephus Carolus Mertens · Oud-Turnhout, BE
Jacbous Alphonsus Josephus Van Dun · Kasterlee, BE
Maria Victorina Francisca Somers · Vosselaar, BE
Walter Boudewijn Leopold Wouters · Kapellen, BE

Key dates

Filing date	Jun 28, 2005
Grant date	Dec 20, 2011
Priority date	—
Expiry date	Sep 8, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I)wherein R1, L1, L2, X, Y and Z have defined meanings.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.